What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Dietger Niederwieser mostly deals with Internal medicine, Transplantation, Surgery, Hematopoietic stem cell transplantation and Gastroenterology.
Dietger Niederwieser interconnects Immunology and Oncology in the investigation of issues within Internal medicine.
His work carried out in the field of Transplantation brings together such families of science as Survival rate, Hematology, Stem cell, Transplantation Conditioning and Fludarabine.
Dietger Niederwieser usually deals with Surgery and limits it to topics linked to Multiple myeloma and Dexamethasone.
The various areas that he examines in his Gastroenterology study include Chemotherapy, Lymphocyte, Graft-versus-host disease, Myelogenous and Acute leukemia.
His work investigates the relationship between Myeloid leukemia and topics such as Acute myeloblastic leukemia that intersect with problems in Pediatrics.
His most cited work include:
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. (2438 citations)
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel (2002 citations)
- Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia (1808 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Transplantation, Surgery, Oncology and Hematopoietic stem cell transplantation.
Dietger Niederwieser combines subjects such as Gastroenterology and Immunology with his study of Internal medicine.
His study looks at the intersection of Transplantation and topics like Stem cell with Disease.
His Surgery research is multidisciplinary, incorporating perspectives in Immunosuppression and Multiple myeloma.
The concepts of his Oncology study are interwoven with issues in Chronic lymphocytic leukemia, Hematology, Allogeneic transplantation and Hematopoietic cell.
His Hematopoietic stem cell transplantation research incorporates themes from Survival rate, Myelodysplastic syndromes, Hazard ratio, Transplantation Conditioning and Acute leukemia.
He most often published in these fields:
- Internal medicine (66.89%)
- Transplantation (48.75%)
- Surgery (30.16%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (66.89%)
- Transplantation (48.75%)
- Oncology (30.73%)
In recent papers he was focusing on the following fields of study:
Dietger Niederwieser mainly focuses on Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Myeloid leukemia.
In Internal medicine, he works on issues like Gastroenterology, which are connected to Fludarabine.
Dietger Niederwieser has included themes like Hematopoietic cell, Retrospective cohort study, Stem cell, Leukemia and Bone marrow in his Transplantation study.
The study incorporates disciplines such as Allogeneic transplantation, Graft-versus-host disease, Rituximab, European LeukemiaNet and Multiple myeloma in addition to Oncology.
Dietger Niederwieser interconnects Survival rate, Immunology, Marrow transplantation, Hazard ratio and Transplantation Conditioning in the investigation of issues within Hematopoietic stem cell transplantation.
His work on Midostaurin is typically connected to Context as part of general Myeloid leukemia study, connecting several disciplines of science.
Between 2016 and 2021, his most popular works were:
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel (2002 citations)
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation (802 citations)
- European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia (160 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
His primary scientific interests are in Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Oncology and Myeloid leukemia.
His Internal medicine study frequently draws connections between related disciplines such as Gastroenterology.
His research integrates issues of Incidence, Intensive care medicine, Stem cell, Disease and Bone marrow in his study of Transplantation.
The various areas that Dietger Niederwieser examines in his Hematopoietic stem cell transplantation study include Transplantation Conditioning, Myelodysplastic syndromes, Cohort and Acute leukemia.
His Oncology study integrates concerns from other disciplines, such as Leukemia, Midostaurin and Proportional hazards model.
In the subject of general Myeloid leukemia, his work in European LeukemiaNet is often linked to In patient, thereby combining diverse domains of study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
